Skip to main content
Clinical Trials/DRKS00034805
DRKS00034805
Recruiting
N/A

Investigation of cognitive dysfunction in patients with advanced skin cancer undergoing systemic therapy

niversitätshautklinik0 sites30 target enrollmentAugust 1, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
C43
Sponsor
niversitätshautklinik
Enrollment
30
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 1, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätshautklinik

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of a tumor of the skin, mucous membrane and/or skin appendages
  • Diagnosis of uveal melanoma
  • Treatment at the study center
  • Signed consent form from the patient or his/her caregiver
  • First\-line therapy for the melanoma

Exclusion Criteria

  • Lack of consent form
  • Known brain metastases
  • Neurological diseases e.g. dementia
  • (Active) drug use
  • Current use of medication with proven cognitive impairment
  • Other cancer (second neoplasm) \=2 years ago
  • (Second) systemic anti\-tumor therapy e.g. chemotherapy or previous immunotherapy
  • Immunosuppression or immunodeficiency

Outcomes

Primary Outcomes

Not specified

Similar Trials